{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:25:58Z","timestamp":1790886358033,"version":"4.1.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:p>Mesonephric adenocarcinoma (MA) and mesonephric-like adenocarcinoma (MLA) are rare gynecological neoplasms that sometimes exhibit morphologic overlap with clear cell carcinoma (CCC), which may lead to diagnostic challenges. Napsin-A is regarded as the most specific immunohistochemical marker of CCC, but its expression in MLA and MA has not been widely investigated. This study investigated the expression of Napsin-A in a series of MAs and MLAs to determine its utility in distinguishing these neoplasms from CCC. The cohort included 32 MLAs arising in the ovary, endometrium, abdominal wall, and sigmoid mesocolon, 13 cervical MLAs, 2 ovarian mesonephric-like carcinosarcomas, and 1 cervical mesonephric carcinosarcoma, with Napsin-A immunohistochemistry performed on whole-slide tissue sections. Napsin-A staining was positive in 17 of 48 cases (35.4%), with focal granular cytoplasmic expression ranging from 1% to 40%. In all, 13\/32 (40.6%) MLAs, 2\/13 (15.4%) MAs, and 2\/3 (66.7%) mesonephric or mesonephric-like carcinosarcomas were positive. Our results demonstrate that Napsin-A is expressed in a significant subset of MLAs and MAs. Given the morphologic and immunohistochemical overlap, this may contribute to misclassification as CCC, especially in cases with ambiguous morphology. Pathologists should be aware of this diagnostic pitfall and employ a panel of markers rather than relying on a single marker.<\/jats:p>","DOI":"10.1097\/pgp.0000000000001118","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T09:01:09Z","timestamp":1747386069000},"page":"526-531","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Napsin-A Expression in Mesonephric and Mesonephric-like Adenocarcinomas: Implications for Distinction From Clear Cell Carcinoma"],"prefix":"10.1097","volume":"44","author":[{"given":"Jelena","family":"Mirkovic","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto"},{"name":"Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Olkhov-Mitsel","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Nofech-Mozes","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto"},{"name":"Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwole","family":"Fadare","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of California San Diego, San Diego, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Glenn","family":"McCluggage","sequence":"additional","affiliation":[{"name":"Department of Pathology, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"key":"R1-20251009","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/his.12895","article-title":"Hormone receptor-negative, thyroid transcription factor 1-positive uterine and ovarian adenocarcinomas: report of a series of mesonephric-like adenocarcinomas","volume":"68","author":"McFarland","year":"2016","journal-title":"Histopathology"},{"key":"R2-20251009","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/PAS.0000000000000958","article-title":"Targeted genomic profiling reveals recurrent KRAS mutations in mesonephric-like adenocarcinomas of the female genital tract","volume":"42","author":"Mirkovic","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R3-20251009","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3390\/jcm10040698","article-title":"Mesonephric-like adenocarcinoma of the endometrium: diagnostic advances to spot this wolf in sheep\u2019s clothing. A review of the literature","volume":"10","author":"Deolet","year":"2021","journal-title":"J Clin Med"},{"key":"R4-20251009","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/PAP.0000000000000342","article-title":"Mesonephric-like adenocarcinoma of the female genital tract: from morphologic observations to a well-characterized carcinoma with aggressive clinical behavior","volume":"29","author":"McCluggage","year":"2022","journal-title":"Adv Anat Pathol"},{"key":"R5-20251009","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pathol.2017.11.084","article-title":"Mesonephric proliferations of the female genital tract","volume":"50","author":"Howitt","year":"2018","journal-title":"Pathology"},{"key":"R6-20251009","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13000-019-0830-4","article-title":"Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Mullerian duct lineage: a case report","volume":"14","author":"Yano","year":"2019","journal-title":"Diagn Pathol"},{"key":"R7-20251009","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/s41379-021-00799-6","article-title":"Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases","volume":"34","author":"da Silva","year":"2021","journal-title":"Mod Pathol"},{"key":"R8-20251009","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/PGP.0000000000000573","article-title":"Ovarian combined low-grade serous and mesonephric-like adenocarcinoma: further evidence for a M\u00fcllerian origin of mesonephric-like adenocarcinoma","volume":"39","author":"McCluggage","year":"2020","journal-title":"Int J Gynecol Pathol"},{"key":"R9-20251009","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/PAS.0000000000001193","article-title":"A combined morphologic and molecular approach to retrospectively identify KRAS-mutated mesonephric-like adenocarcinomas of the endometrium","volume":"43","author":"Kolin","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R10-20251009","doi-asserted-by":"crossref","first-page":"101049","DOI":"10.1016\/j.gore.2022.101049","article-title":"Somatic mutation analysis of mesonephric-like adenocarcinoma and associated putative precursor Lesions: Insight into pathogenesis and potential molecular treatment targets","volume":"42","author":"Arslanian","year":"2022","journal-title":"Gynecol Oncol Rep"},{"key":"R11-20251009","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/PAS.0000000000001612","article-title":"Clinicopathologic characteristics of mesonephric adenocarcinomas and mesonephric-like adenocarcinomas in the gynecologic tract: a multi-institutional study","volume":"45","author":"Pors","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R12-20251009","first-page":"70","article-title":"Morphologic and other clinicopathologic features of endometrial clear cell carcinoma: a comprehensive analysis of 50 rigorously classified cases","volume":"3","author":"Fadare","year":"2013","journal-title":"Am J Cancer Res"},{"key":"R13-20251009","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/PAI.0000000000000801","article-title":"Napsin-A and AMACR are superior to HNF-1beta in distinguishing between mesonephric carcinomas and clear cell carcinomas of the gynecologic tract","volume":"28","author":"Pors","year":"2020","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R14-20251009","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/PAS.0000000000000085","article-title":"Frequent expression of napsin A in clear cell carcinoma of the endometrium: potential diagnostic utility","volume":"38","author":"Fadare","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R15-20251009","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/modpathol.2014.61","article-title":"Napsin A is a specific marker for ovarian clear cell adenocarcinoma","volume":"28","author":"Yamashita","year":"2015","journal-title":"Mod Pathol"},{"key":"R16-20251009","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.humpath.2015.03.008","article-title":"Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium","volume":"46","author":"Iwamoto","year":"2015","journal-title":"Hum Pathol"},{"key":"R17-20251009","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/PAS.0000000000001766","article-title":"Extrauterine mesonephric-like neoplasms: expanding the morphologic spectrum","volume":"46","author":"Deolet","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R18-20251009","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/PAS.0000000000001401","article-title":"Mesonephric-like carcinoma of the endometrium: a subset of endometrial carcinoma with an aggressive behavior","volume":"44","author":"Euscher","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R19-20251009","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/PAS.0000000000002039","article-title":"Extrauterine mesonephric-like carcinoma: a comprehensive single institution study of 33 cases","volume":"47","author":"Euscher","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"R20-20251009","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00432-019-03123-7","article-title":"Mesonephric-like adenocarcinomas of the uterine corpus: report of a case series and review of the literature indicating poor prognosis for this subtype of endometrial adenocarcinoma","volume":"146","author":"Horn","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"R21-20251009","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.3390\/diagnostics11112042","article-title":"Mesonephric-like adenocarcinoma of the uterine corpus: comprehensive immunohistochemical analyses using markers for mesonephric, endometrioid and serous tumors","volume":"11","author":"Kim","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"R22-20251009","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/PAS.0000000000001873","article-title":"Mesonephric-like endometrial carcinoma: results from immunohistochemical screening of 300 endometrial carcinomas and carcinosarcomas for this often overlooked and potentially aggressive entity","volume":"46","author":"Mills","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R23-20251009","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/PAS.0000000000000991","article-title":"Clinicopathologic and molecular characteristics of mesonephric adenocarcinoma arising from the uterine body","volume":"43","author":"Na","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R24-20251009","doi-asserted-by":"crossref","first-page":"526","DOI":"10.21873\/cgp.20338","article-title":"Mesonephric-like adenocarcinoma of the uterine corpus: comprehensive analyses of clinicopathological, molecular, and prognostic characteristics with retrospective review of 237 endometrial carcinoma cases","volume":"19","author":"Kim","year":"2022","journal-title":"Cancer Genomics Proteomics"},{"key":"R26-20251009","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/PAS.0b013e31824a72c6","article-title":"Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-beta","volume":"36","author":"Kenny","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R27-20251009","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3390\/diagnostics12020326","article-title":"Mesonephric-like adenocarcinoma of the ovary: clinicopathological and molecular characteristics","volume":"12","author":"Koh","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"R28-20251009","doi-asserted-by":"crossref","first-page":"e12389","DOI":"10.1002\/2056-4538.12389","article-title":"Mesonephric-type adenocarcinomas of the ovary: prevalence, diagnostic reproducibility, outcome, and value of PAX2","volume":"10","author":"Kobel","year":"2024","journal-title":"J Pathol Clin Res"},{"key":"R29-20251009","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/modpathol.2008.4","article-title":"Thyroid transcription factor-1 expression in ovarian epithelial neoplasms","volume":"21","author":"Kubba","year":"2008","journal-title":"Mod Pathol"},{"key":"R30-20251009","doi-asserted-by":"crossref","first-page":"218","DOI":"10.30699\/ijp.2024.2016228.3217","article-title":"Prevalence and pattern of GATA3 Immunohistochemical expression in female genital tract adenocarcinomas","volume":"19","author":"Mirzaian","year":"2024","journal-title":"Iran J Pathol"},{"key":"R31-20251009","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/00000478-200302000-00005","article-title":"CD10 expression in epithelial tissues and tumors of the gynecologic tract: a useful marker in the diagnosis of mesonephric, trophoblastic, and clear cell tumors","volume":"27","author":"Ordi","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R32-20251009","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1097\/PAS.0000000000001142","article-title":"A comparison of GATA3, TTF1, CD10, and calretinin in identifying mesonephric and mesonephric-like carcinomas of the gynecologic tract","volume":"42","author":"Pors","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R33-20251009","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/PGP.0000000000000541","article-title":"GATA3 expression in common gynecologic carcinomas: a potential pitfall","volume":"38","author":"Terzic","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"R34-20251009","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/PGP.0b013e3181804bc6","article-title":"TTF-1 expression in ovarian and uterine epithelial neoplasia and its potential significance, an immunohistochemical assessment with multiple monoclonal antibodies and different secondary detection systems","volume":"28","author":"Zhang","year":"2009","journal-title":"Int J Gynecol Pathol"},{"key":"R35-20251009","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/01.PGP.0000071044.12278.43","article-title":"A panel of immunohistochemical stains assists in the distinction between ovarian and renal clear cell carcinoma","volume":"22","author":"Cameron","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"R36-20251009","doi-asserted-by":"crossref","first-page":"619","DOI":"10.4103\/ijpm.ijpm_518_23","article-title":"Clear cell adenocarcinoma of the cervix and its mimickers\u2014a series of 19 cases from a tertiary care referral centre in India","volume":"67","author":"Thomas","year":"2024","journal-title":"Indian J Pathol Microbiol"},{"key":"R37-20251009","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/his.15136","article-title":"The first evidence of mismatch repair deficiency in mesonephric-like adenocarcinoma of the endometrium: clinicopathological and molecular features of a case emphasising a possible endometrioid carcinogenesis","volume":"84","author":"Angelico","year":"2024","journal-title":"Histopathology"},{"key":"R38-20251009","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/modpathol.2015.103","article-title":"Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract","volume":"28","author":"Mirkovic","year":"2015","journal-title":"Mod Pathol"},{"key":"R39-20251009","doi-asserted-by":"crossref","first-page":"911695","DOI":"10.3389\/fonc.2022.911695","article-title":"Mesonephric-like adenocarcinoma of uterine corpus: a clinicopathological and targeted genomic profiling study in a single institution","volume":"12","author":"Ma","year":"2022","journal-title":"Front Oncol"},{"key":"R40-20251009","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/COC.0000000000000641","article-title":"Genomic and molecular abnormalities in gynecologic clear cell carcinoma","volume":"43","author":"Marks","year":"2020","journal-title":"Am J Clin Oncol"},{"key":"R41-20251009","doi-asserted-by":"crossref","first-page":"15727","DOI":"10.1007\/s00432-023-05306-9","article-title":"Mesonephric-like adenocarcinoma of the female genital tract: possible role of KRAS-targeted treatment-detailed molecular analysis of a case series and review of the literature for targetable somatic KRAS-mutations","volume":"149","author":"Brambs","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"R42-20251009","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ygyno.2021.07.007","article-title":"Clear cell endometrial carcinomas with mismatch repair deficiency have a favorable prognosis: a systematic review and meta-analysis","volume":"162","author":"Travaglino","year":"2021","journal-title":"Gynecol Oncol"},{"key":"R43-20251009","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1158\/1078-0432.CCR-24-1205","article-title":"Unveiling commonalities: exploring shared characteristics in clear-cell carcinomas of the gynecologic tract","volume":"30","author":"Blanc-Durand","year":"2024","journal-title":"Clin Cancer Res"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000001118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:00:41Z","timestamp":1760025641000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000001118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000001118","relation":{},"ISSN":["0277-1691","1538-7151"],"issn-type":[{"value":"0277-1691","type":"print"},{"value":"1538-7151","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]}}}